488 results on '"Norris A"'
Search Results
2. Inhibition of CtBP-Regulated Proinflammatory Gene Transcription Attenuates Psoriatic Skin Inflammation
3. Phosphodiesterase-4 Inhibitors Increase Pigment Cell Proliferation and Melanization in Cultured Melanocytes and within a 3-Dimensional Skin Equivalent Model
4. Expression Differences in BCL2 Family Members between Uveal and Cutaneous Melanomas Account for Varying Sensitivity to BH3 Mimetics
5. Differences in Clinical Features and Comorbid Burden between HLA-C∗06:02 Carrier Groups in >9,000 People with Psoriasis
6. SASH1 S519N variant links skin hyperpigmentation and premature hair graying to dysfunction of melanocyte lineage
7. Melanocyte Precursors in the Hair Follicle Bulge of Repigmented Vitiligo Skin Are Controlled by RHO-GTPase, KCTD10, and CTNNB1 Signaling
8. Harnessing the Power of Regenerative Therapy for Vitiligo and Alopecia Areata
9. Repigmentation of Human Vitiligo Skin by NBUVB Is Controlled by Transcription of GLI1 and Activation of the β-Catenin Pathway in the Hair Follicle Bulge Stem Cells
10. 1262 Immuno-apoptotic priming to enhance the efficacy of immunotherapies in melanoma
11. Alternative Treatments For Melanoma: Targeting BCL-2 Family Members to De-Bulk and Kill Cancer Stem Cells
12. Narrow Band Ultraviolet B Treatment for Human Vitiligo Is Associated with Proliferation, Migration, and Differentiation of Melanocyte Precursors
13. Combining a BCL2 Inhibitor with the Retinoid Derivative Fenretinide Targets Melanoma Cells Including Melanoma Initiating Cells
14. MicroRNA-26a Is Strongly Downregulated in Melanoma and Induces Cell Death through Repression of Silencer of Death Domains (SODD)
15. CtBP1 Is Expressed in Melanoma and Represses the Transcription of p16INK4a and Brca1
16. Dual Role of Apoptosis-Associated Speck-Like Protein Containing a CARD (ASC) in Tumorigenesis of Human Melanoma
17. Side Population Cells from Human Melanoma Tumors Reveal Diverse Mechanisms for Chemoresistance
18. 575 Molecular characterization of trametinib-induced cardiotoxicity
19. LB999 Basal levels of MCL1 and its binding partners contribute to a higher sensitivity to MCL1 inhibitors in uveal vs cutaneous melanomas
20. LB943 Tofacitinib treatment of inflammatory skin conditions in patients with Down Syndrome
21. Differences in Clinical Features and Comorbid Burden between HLA-C∗06:02 Carrier Groups in >9,000 People with Psoriasis
22. 1262 Immuno-apoptotic priming to enhance the efficacy of immunotherapies in melanoma
23. 607 MCL1 inhibition targets myeloid derived suppressors cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade
24. BH3 Mimetic ABT-737 and a Proteasome Inhibitor Synergistically Kill Melanomas through Noxa-Dependent Apoptosis
25. Active N-Ras and B-Raf Inhibit Anoikis by Downregulating Bim Expression in Melanocytic Cells
26. LB999 Basal levels of MCL1 and its binding partners contribute to a higher sensitivity to MCL1 inhibitors in uveal vs cutaneous melanomas
27. 575 Molecular characterization of trametinib-induced cardiotoxicity
28. LB943 Tofacitinib treatment of inflammatory skin conditions in patients with Down Syndrome
29. Hyperthermia Induces Endoplasmic Reticulum-Mediated Apoptosis in Melanoma and Non-Melanoma Skin Cancer Cells
30. 543 The high expression of pro-apoptotic BCL2 family members in uveal melanomas contribute to their sensitivity to MCL1 inhibitors
31. RhoC Promotes Human Melanoma Invasion in a PI3K/Akt-Dependent Pathway
32. George W. Hambrick Jr (1922–2013)
33. 608 Targeting CtBP-mediated proinflammatory gene transcription to treat skin inflammation
34. 674 The effective killing of the difficult-to-treat melanomas with the combinations of MCL1 inhibitors S63845/MIK665 plus Navitoclax
35. Genome Scans Provide Evidence for Keloid Susceptibility Loci on Chromosomes 2q23 and 7p11
36. 543 The high expression of pro-apoptotic BCL2 family members in uveal melanomas contribute to their sensitivity to MCL1 inhibitors
37. Release of Vascular Endothelial Growth Factor from a Human Melanoma Cell Line, WM35, Is Induced by Hypoxia but Not Ultraviolet Radiation and Is Potentiated by Activated Ras Mutation
38. 608 Targeting CtBP-mediated proinflammatory gene transcription to treat skin inflammation
39. 674 The effective killing of the difficult-to-treat melanomas with the combinations of MCL1 inhibitors S63845/MIK665 plus Navitoclax
40. 814 RHOJ knockdown modulates the migration and differentiation of normal human melanocytes and the expression of pro-apoptotic markers after UV exposure
41. 393 Rare genetic mutations identify extracellular matrix genes as a contributing factor in alopecia areata etiology
42. 840 Aberrant differentiation as a novel mechanism for lentigines and hair graying
43. Regulation of Fas-Mediated Apoptosis by N-ras in Melanoma
44. Tyrosinase Gene Expression is Regulated by p53
45. Oligoclonal Expansion of Intraepidermal T Cells in Psoriasis Skin Lesions
46. 840 Aberrant differentiation as a novel mechanism for lentigines and hair graying
47. 393 Rare genetic mutations identify extracellular matrix genes as a contributing factor in alopecia areata etiology
48. 814 RHOJ knockdown modulates the migration and differentiation of normal human melanocytes and the expression of pro-apoptotic markers after UV exposure
49. A Distinct Genotype of XP Complementation Group A: Surprisingly Mild Phenotype Highly Prevalent in Northern India/Pakistan/Afghanistan
50. 1229 Aberrant differentiation as a novel mechanism for hyperpigmentation disorders
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.